SIGA Technologies

Yahoo Finance • last month

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -... Full story

Yahoo Finance • 5 months ago

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. “We continue... Full story

Yahoo Finance • 7 months ago

Mpox in Africa is no longer a global health emergency, WHO chief says

[Blood collection tubes Mpox test positive results,WHO to rename monkeypox as ‘Mpox’] JUN LI The mpox outbreak that originated from Africa last year can no longer be considered a global emergency due to a sustained decline in cases and im... Full story

Yahoo Finance • 8 months ago

Validea Motley Fool Strategy Daily Upgrade Report - 8/12/2025

The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance. REX AME... Full story

Yahoo Finance • 8 months ago

SIGA advances pediatric and PEP programs as product revenues reach $79M, supported by new BARDA funding

Earnings Call Insights: SIGA Technologies, Inc. (SIGA) Q2 2025 MANAGEMENT VIEW * CEO Diem Nguyen highlighted that "SIGA continues to make steady progress as we advance our strategic initiatives. The evolving global landscape calls for... Full story

Yahoo Finance • 8 months ago

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the Three Months Ended Jun... Full story

Yahoo Finance • 8 months ago

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story

Yahoo Finance • last year

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the... Full story

Yahoo Finance • last year

SIGA Appoints Retired General John M. Keane to its Board of Directors

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army General John “Jack” Keane to its Board o... Full story

Yahoo Finance • last year

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Increased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million, Respectively, in 2024Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 11, 2025 (GLOBE N... Full story

Yahoo Finance • last year

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update a... Full story

Yahoo Finance • 2 years ago

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

SIGA Technologies Inc. NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., wi... Full story

Yahoo Finance • 2 years ago

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023

- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by European Commission with Anticipated Ini... Full story

Yahoo Finance • 2 years ago

SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story

Yahoo Finance • 2 years ago

SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission’s DG HERA... Full story

Yahoo Finance • 3 years ago

SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executi... Full story

Yahoo Finance • 3 years ago

SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that SIGA CEO Phil Gomez, PhD, will present an ov... Full story

Yahoo Finance • 3 years ago

SIGA Declares Special Cash Dividend of $0.45 Per Share

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special cash dividend of $0.45 per share on the c... Full story

Yahoo Finance • 3 years ago

SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update a... Full story

Yahoo Finance • 3 years ago

Q4 2022 SIGA Technologies Inc Earnings Call

Participants Daniel J. Luckshire; Executive VP, CFO & Secretary; SIGA Technologies, Inc. Phillip Louis Gomez; CEO & Director; SIGA Technologies, Inc. Soo Romanoff; Analyst; Edison Investment Research Limited Presentation Operator Lad... Full story